0000000000918784

AUTHOR

María-remedios Marqués-miñana

showing 1 related works from this author

Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline

2010

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Vancomycin is a glycopeptide antibiotic commonly used to treat resistant gram-positive infections in neonates. While adult dosing guidelines are generally well established, a lack of consensus for optimal dosing regimens in neonates remains. • The large variance in pharmacokinetic values in premature neonates compared with full-term infants is a major barrier to the development of optimal dosing regimens. Pharmacokinetic values have been reported for vancomycin in neonates. However, the studies have included small groups with differing, clinical conditions, serum sampling times and pharmacokinetic models. There are many proposed neonatal dosing gui…

PharmacologyVolume of distributionPediatricsmedicine.medical_specialtyeducation.field_of_studymedicine.drug_classbusiness.industryPopulationGlycopeptide antibioticPharmacologyNONMEMPharmacokineticsmedicineVancomycinPharmacology (medical)Dosingbusinesseducationmedicine.drugAntibacterial agentBritish Journal of Clinical Pharmacology
researchProduct